Dynavax Technologies (DVAX) Competitors $11.75 +0.20 (+1.73%) Closing price 04/30/2025 04:00 PM EasternExtended Trading$11.40 -0.35 (-2.94%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DVAX vs. IONS, ALKS, FOLD, LGND, BCRX, MNKD, CLDX, INVA, NVAX, and OPKShould you be buying Dynavax Technologies stock or one of its competitors? The main competitors of Dynavax Technologies include Ionis Pharmaceuticals (IONS), Alkermes (ALKS), Amicus Therapeutics (FOLD), Ligand Pharmaceuticals (LGND), BioCryst Pharmaceuticals (BCRX), MannKind (MNKD), Celldex Therapeutics (CLDX), Innoviva (INVA), Novavax (NVAX), and OPKO Health (OPK). These companies are all part of the "biotechnology" industry. Dynavax Technologies vs. Ionis Pharmaceuticals Alkermes Amicus Therapeutics Ligand Pharmaceuticals BioCryst Pharmaceuticals MannKind Celldex Therapeutics Innoviva Novavax OPKO Health Ionis Pharmaceuticals (NASDAQ:IONS) and Dynavax Technologies (NASDAQ:DVAX) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Does the MarketBeat Community prefer IONS or DVAX? Ionis Pharmaceuticals received 229 more outperform votes than Dynavax Technologies when rated by MarketBeat users. However, 65.84% of users gave Dynavax Technologies an outperform vote while only 60.36% of users gave Ionis Pharmaceuticals an outperform vote. CompanyUnderperformOutperformIonis PharmaceuticalsOutperform Votes70560.36% Underperform Votes46339.64% Dynavax TechnologiesOutperform Votes47665.84% Underperform Votes24734.16% Which has preferable valuation & earnings, IONS or DVAX? Dynavax Technologies has lower revenue, but higher earnings than Ionis Pharmaceuticals. Ionis Pharmaceuticals is trading at a lower price-to-earnings ratio than Dynavax Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIonis Pharmaceuticals$705.14M6.92-$366.29M-$3.04-10.10Dynavax Technologies$277.25M5.19-$6.39M$0.1865.28 Which has more volatility and risk, IONS or DVAX? Ionis Pharmaceuticals has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500. Comparatively, Dynavax Technologies has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Do analysts rate IONS or DVAX? Ionis Pharmaceuticals presently has a consensus target price of $56.44, indicating a potential upside of 83.80%. Dynavax Technologies has a consensus target price of $20.50, indicating a potential upside of 74.47%. Given Ionis Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Ionis Pharmaceuticals is more favorable than Dynavax Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ionis Pharmaceuticals 1 Sell rating(s) 6 Hold rating(s) 11 Buy rating(s) 2 Strong Buy rating(s) 2.70Dynavax Technologies 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is IONS or DVAX more profitable? Dynavax Technologies has a net margin of 9.85% compared to Ionis Pharmaceuticals' net margin of -64.25%. Dynavax Technologies' return on equity of 4.22% beat Ionis Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Ionis Pharmaceuticals-64.25% -100.05% -15.70% Dynavax Technologies 9.85%4.22%2.67% Does the media refer more to IONS or DVAX? In the previous week, Ionis Pharmaceuticals had 14 more articles in the media than Dynavax Technologies. MarketBeat recorded 20 mentions for Ionis Pharmaceuticals and 6 mentions for Dynavax Technologies. Ionis Pharmaceuticals' average media sentiment score of 1.17 beat Dynavax Technologies' score of 1.00 indicating that Ionis Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ionis Pharmaceuticals 13 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Dynavax Technologies 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in IONS or DVAX? 93.9% of Ionis Pharmaceuticals shares are held by institutional investors. Comparatively, 97.0% of Dynavax Technologies shares are held by institutional investors. 2.7% of Ionis Pharmaceuticals shares are held by insiders. Comparatively, 3.0% of Dynavax Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryDynavax Technologies beats Ionis Pharmaceuticals on 10 of the 19 factors compared between the two stocks. Get Dynavax Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DVAX vs. The Competition Export to ExcelMetricDynavax TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.44B$6.89B$5.56B$7.82BDividend YieldN/A3.05%5.11%4.22%P/E Ratio65.287.4422.5718.48Price / Sales5.19242.70395.64103.60Price / CashN/A65.8538.1834.62Price / Book2.446.516.774.25Net Income-$6.39M$143.21M$3.22B$248.23M7 Day Performance7.80%1.97%1.46%0.89%1 Month Performance-7.55%6.89%3.98%3.53%1 Year Performance0.60%-2.52%16.14%5.09% Dynavax Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DVAXDynavax Technologies4.2926 of 5 stars$11.75+1.7%$20.50+74.5%+3.3%$1.44B$277.25M65.28350Upcoming EarningsIONSIonis Pharmaceuticals4.1826 of 5 stars$29.74+0.1%$56.72+90.7%-25.6%$4.73B$705.14M-9.78800Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpALKSAlkermes4.617 of 5 stars$27.91+0.3%$38.08+36.5%+17.2%$4.60B$1.56B12.862,280Earnings ReportAnalyst ForecastNews CoverageFOLDAmicus Therapeutics4.3734 of 5 stars$7.39+0.5%$16.75+126.7%-23.1%$2.27B$528.30M-41.06480Earnings ReportNews CoveragePositive NewsLGNDLigand Pharmaceuticals4.3875 of 5 stars$108.88+0.7%$146.43+34.5%+57.2%$2.10B$167.13M43.3880Upcoming EarningsNews CoverageBCRXBioCryst Pharmaceuticals4.4625 of 5 stars$8.32-0.8%$15.57+87.2%+114.3%$1.74B$450.71M-13.64530Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageMNKDMannKind3.1294 of 5 stars$4.73-0.2%$9.56+102.2%+22.6%$1.44B$285.50M67.57400Upcoming EarningsPositive NewsCLDXCelldex Therapeutics1.9841 of 5 stars$21.36+9.1%$55.30+158.9%-44.3%$1.42B$7.02M-8.31150Positive NewsINVAInnoviva4.2229 of 5 stars$18.38+0.8%$55.00+199.2%+23.7%$1.15B$358.71M26.64100Upcoming EarningsAnalyst UpgradeNews CoveragePositive NewsNVAXNovavax3.6228 of 5 stars$6.70+0.4%$18.00+168.7%+54.0%$1.08B$682.16M-2.961,990OPKOPKO Health4.4662 of 5 stars$1.41flat$2.75+95.0%+13.1%$946.89M$713.14M-7.424,200Earnings ReportNews Coverage Related Companies and Tools Related Companies IONS Competitors ALKS Competitors FOLD Competitors LGND Competitors BCRX Competitors MNKD Competitors CLDX Competitors INVA Competitors NVAX Competitors OPK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DVAX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynavax Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynavax Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DVAX Stock Free DVAX Stock Alerts